PMID- 35677020
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220716
IS  - 2325-9671 (Print)
IS  - 2325-9671 (Electronic)
IS  - 2325-9671 (Linking)
VI  - 10
IP  - 6
DP  - 2022 Jun
TI  - Outcomes and Return-to-Sport Rates for Elite Athletes With Femoral Retroversion 
      Undergoing Hip Arthroscopy: A Propensity-Matched Analysis With Minimum 2-Year 
      Follow-up.
PG  - 23259671221099840
LID - 10.1177/23259671221099840 [doi]
LID - 23259671221099840
AB  - BACKGROUND: Return to sports (RTS) and patient-reported outcomes (PROs) for elite 
      athletes with femoral version abnormalities undergoing hip arthroscopy have not 
      been well established. PURPOSES: To (1) report minimum 2-year PROs and RTS rates 
      in elite athletes with femoral retroversion who underwent primary hip arthroscopy 
      and (2) compare clinical results to those of a propensity-matched control group 
      of elite athletes with normal femoral version who underwent primary hip 
      arthroscopy. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: Data were 
      prospectively collected and retrospectively reviewed for elite (professional and 
      collegiate) athletes with femoral version <5 degrees , as measured on magnetic resonance 
      imaging scans, who underwent hip arthroscopy for femoroacetabular impingement 
      syndrome between March 2010 and April 2018. Inclusion criteria were preoperative 
      and minimum 2-year follow-up PROs for the modified Harris Hip Score, Nonarthritic 
      Hip Score, Hip Outcome Score-Sports Specific Subscale (HOS-SSS), and visual 
      analog scale for pain. Exclusion criteria were Tonnis grade >1, hip dysplasia, 
      and previous ipsilateral hip surgery or conditions. Rates of achieving the 
      minimal clinically important difference (MCID), Patient Acceptable Symptom State 
      (PASS), and maximum outcome improvement satisfaction threshold were recorded in 
      addition to RTS. Athletes with retroversion were propensity matched in a 1:2 
      ratio to elite athletes with normal femoral version (5 degrees -20 degrees ) for comparison. 
      RESULTS: A total of 33 elite athletes (33 hips) with femoral retroversion who 
      underwent hip arthroscopy met the inclusion criteria, and follow-up was available 
      for 30 hips in 30 athletes (90.9%) at an average of 36.1 +/- 25.6 months. Elite 
      athletes with femoral retroversion demonstrated significant improvements in all 
      recorded PROs, achieved the MCID and PASS for the HOS-SSS at high rates (86.7%), 
      and returned to sports at a rate of 83.3%. PROs, rates of achieving MCID and PASS 
      for the HOS-SSS, and RTS rates were similar between the study and 
      propensity-matched control group. CONCLUSION: Elite athletes with femoral 
      retroversion undergoing primary hip arthroscopy demonstrated favorable PROs and 
      high RTS rates at a minimum 2-year follow-up. These results were comparable with 
      those of a propensity-matched control group of elite athletes with normal femoral 
      version.
CI  - (c) The Author(s) 2022.
FAU - Owens, Jade S
AU  - Owens JS
AD  - American Hip Institute Research Foundation, Chicago, Illinois, USA.
FAU - Jimenez, Andrew E
AU  - Jimenez AE
AD  - American Hip Institute Research Foundation, Chicago, Illinois, USA.
FAU - Lee, Michael S
AU  - Lee MS
AD  - American Hip Institute Research Foundation, Chicago, Illinois, USA.
FAU - Maldonado, David R
AU  - Maldonado DR
AD  - American Hip Institute Research Foundation, Chicago, Illinois, USA.
FAU - Lall, Ajay C
AU  - Lall AC
AD  - American Hip Institute Research Foundation, Chicago, Illinois, USA.
AD  - American Hip Institute, Chicago, Illinois, USA.
FAU - Domb, Benjamin G
AU  - Domb BG
AD  - American Hip Institute Research Foundation, Chicago, Illinois, USA.
AD  - American Hip Institute, Chicago, Illinois, USA.
LA  - eng
PT  - Journal Article
DEP - 20220603
PL  - United States
TA  - Orthop J Sports Med
JT  - Orthopaedic journal of sports medicine
JID - 101620522
PMC - PMC9168879
OTO - NOTNLM
OT  - athletes
OT  - femoroacetabular impingement syndrome
OT  - hip arthroscopy
OT  - return to sport
OT  - version
COIS- One or more of the authors has declared the following potential conflict of 
      interest or source of funding: A.E.J. has received education payments from 
      Medwest. A.C.L. has received grant support from Arthrex and Stryker, education 
      payments from Arthrex and Smith & Nephew, consulting fees from Graymont 
      Professional, and nonconsulting fees from Arthrex. B.G.D. has received education 
      payments from Medwest; consulting fees from Arthrex, Medacta, and Stryker; 
      speaking fees from Arthrex and Stryker; and royalties from Arthrex, DJO, and 
      Medacta. AOSSM checks author disclosures against the Open Payments Database 
      (OPD). AOSSM has not conducted an independent investigation on the OPD and 
      disclaims any liability or responsibility relating thereto.
EDAT- 2022/06/10 06:00
MHDA- 2022/06/10 06:01
PMCR- 2022/06/03
CRDT- 2022/06/09 02:05
PHST- 2022/02/10 00:00 [received]
PHST- 2022/03/22 00:00 [accepted]
PHST- 2022/06/09 02:05 [entrez]
PHST- 2022/06/10 06:00 [pubmed]
PHST- 2022/06/10 06:01 [medline]
PHST- 2022/06/03 00:00 [pmc-release]
AID - 10.1177_23259671221099840 [pii]
AID - 10.1177/23259671221099840 [doi]
PST - epublish
SO  - Orthop J Sports Med. 2022 Jun 3;10(6):23259671221099840. doi: 
      10.1177/23259671221099840. eCollection 2022 Jun.